Live feed
Filing
SC 13D/A
SC 13D/A0001193125-17-329703·Allergan plc
Schedule 13D ownership disclosure
TEVA PHARMACEUTICAL INDS LTD
Security class unavailable · CUSIP: 881624209
Event date: 2017-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-329703
- Form type
- SC 13D/A
- Filer
- Allergan plc
- CIK
- CIK 1578845
- Filed
- Nov 01, 2017
- Reporting period
- Nov 01, 2017
- Description
- Schedule 13D beneficial ownership